Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Skye Bioscience, Inc.

NASDAQ: SKYE · Life Sciences · 6 alerts · CIK 1516551

Share price
$1.07Close, Nov 16
Market cap
$4.71M
Shares outstanding
4.42MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Skye Bioscience, Inc. filings on SEC EDGAR ↗

4:07 PM ET 10-Q
Financial Results

Skye Bioscience Q3 2026 Results: Turns Profitable, Net Income $69.1K

Skye Bioscience reported a significant decrease in cash and short-term investments from $25.7 million at year-end 2025 to $4.8 million as of September 30, 2026. The company experienced a net loss of $23.2 million for the first nine months of 2026, driven primarily by $13.2 million in research and development expenses. A 1-for-8 reverse stock split was effected on August 24, 2026.

Key figure
Net income $69.1K

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.